Abrogation of the p38 MAPK α signaling pathway does not promote radioresistance but its activity is required for 5-Fluorouracil-associated radiosensitivity-Reference-Cited by-同舟云学术

Abrogation of the p38 MAPK α signaling pathway does not promote radioresistance but its activity is required for 5-Fluorouracil-associated radiosensitivity

Published:2013-07 Issue:1 Volume:335 Page:66-74
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

de la Cruz-Morcillo Miguel A.,García-Cano Jesús,Arias-González Laura,García-Gil Elena,Artacho-Cordón Francisco,Ríos-Arrabal Sandra,Valero María L.,Cimas Francisco J.,Serrano-Oviedo Leticia,Villas María V.,Romero-Fernández Jesús,Núñez María I.,Sánchez-Prieto Ricardo

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference41 articles.

1. MAP kinase pathways: the first twenty years;Avruch;Biochim. Biophys. Acta,2007

2. Mechanisms and functions of p38 MAPK signalling;Cuadrado;Biochem. J.,2010

3. P38 MAP-kinases pathway regulation, function and role in human diseases;Cuenda;Biochim. Biophys. Acta,2007

4. P38MAPK is a major determinant of the balance between apoptosis and autophagy triggered by 5-fluorouracil: implication in resistance;de la Cruz-Morcillo;Oncogene,2012

5. Balance between MKK6 and MKK3 mediates p38 MAPK associated resistance to cisplatin in NSCLC;Galan-Moya;PLoS One,2011

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The signalling axis CDK12-BRCA1 mediates dinaciclib associated radiosensitivity through p53-mediated cellular senescence;2024-04-28

2. MAPK11 (p38β) is a major determinant of cellular radiosensitivity by controlling ionizing radiation-associated senescence: An in vitro study;Clinical and Translational Radiation Oncology;2023-07

3. P38 MAPK and Radiotherapy: Foes or Friends?;Cancers;2023-01-30

4. MAPK11 (p38β) is a major determinant of cellular radiosensitivity by enhancing IR-associated senescence;2022-09-13

5. Downregulation of KRAB zinc finger proteins in 5-fluorouracil resistant colorectal cancer cells;BMC Cancer;2022-04-04